These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22309049)

  • 1. Mechanism of anti-platelet activity of Oligoporus tephroleucus oligoporin A: involvement of extracellular signal-regulated kinase phosphorylation and cyclic nucleotide elevation.
    Park JY; Oh WJ; Kim MJ; Kim TH; Cho JY; Park HJ; Lee IK; Kim S; Kim GS; Kim SK; Seo GS; Yun BS; Rhee MH
    Platelets; 2012; 23(5):376-85. PubMed ID: 22309049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase.
    Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim TH; Lee IK; Cho JY; Park HJ; Kim SK; Yun BS; Rhee MH
    Phytother Res; 2011 Nov; 25(11):1596-603. PubMed ID: 21394810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
    Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
    Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ADP-induced platelet adhesion to immobilised fibrinogen by nitric oxide: evidence for cGMP-independent mechanisms.
    Oberprieler NG; Roberts W; Graham AM; Homer-Vanniasinkam S; Naseem KM
    Biochem Pharmacol; 2007 May; 73(10):1593-601. PubMed ID: 17306768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase.
    Kim SD; Lee IK; Lee WM; Cho JY; Park HJ; Oh JW; Park SC; Kim SK; Kwak YS; Yun BS; Rhee MH
    Eur J Pharmacol; 2008 Apr; 584(2-3):361-7. PubMed ID: 18313047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling.
    Vaiyapuri S; Ali MS; Moraes LA; Sage T; Lewis KR; Jones CI; Gibbins JM
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2740-9. PubMed ID: 24135020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of beta 2-glycoprotein-I upon the content of cAMP and cGMP in human blood platelets.
    Nimpf J; Gries A; Wurm H; Kostner GM
    Thromb Haemost; 1985 Dec; 54(4):824-7. PubMed ID: 3003956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
    Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
    Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH
    Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of Bulnesia sarmienti aqueous extract on agonist-induced platelet activation and thrombus formation involves mitogen-activated protein kinases.
    Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim KS; Hong JH; Kwak YS; Yun BS; Rhee MH
    J Ethnopharmacol; 2010 Aug; 130(3):614-20. PubMed ID: 20558266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory mechanisms of dihydroginsenoside Rg3 in platelet aggregation: critical roles of ERK2 and cAMP.
    Lee WM; Kim SD; Park MH; Cho JY; Park HJ; Seo GS; Rhee MH
    J Pharm Pharmacol; 2008 Nov; 60(11):1531-6. PubMed ID: 18957175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet aggregation by chlorogenic acid via cAMP and cGMP-dependent manner.
    Cho HJ; Kang HJ; Kim YJ; Lee DH; Kwon HW; Kim YY; Park HJ
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):629-35. PubMed ID: 22885765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
    Wang WY; Wu YC; Wu CC
    Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases.
    Lu Y; Li Q; Liu YY; Sun K; Fan JY; Wang CS; Han JY
    Sci Rep; 2015 Sep; 5():13824. PubMed ID: 26345207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p-Terphenyl curtisian E inhibits in vitro platelet aggregation via cAMP elevation and VASP phosphorylation.
    Kamruzzaman SM; Yayeh T; Ji HD; Park JY; Kwon YS; Lee IK; Kim S; Oh SH; Kim SD; Roh SS; Yun BS; Rhee MH
    Vascul Pharmacol; 2013; 59(3-4):83-9. PubMed ID: 23872194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function.
    Aszódi A; Pfeifer A; Ahmad M; Glauner M; Zhou XH; Ny L; Andersson KE; Kehrel B; Offermanns S; Fässler R
    EMBO J; 1999 Jan; 18(1):37-48. PubMed ID: 9878048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling.
    Marwali MR; Hu CP; Mohandas B; Dandapat A; Deonikar P; Chen J; Cawich I; Sawamura T; Kavdia M; Mehta JL
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1324-32. PubMed ID: 17538005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activity is negatively modulated by tumor necrosis factor alpha through reductions of cytosolic calcium levels and integrin alphaIIbbeta3 phosphorylation.
    Bonfitto PHL; Naime ACA; Lopes-Pires ME; Goulart G; Mendes-Silverio CB; Bueno PI; Castilho RF; Antunes E; Marcondes S
    Thromb Res; 2018 Dec; 172():44-50. PubMed ID: 30359790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP.
    Shen MY; Hsiao G; Liu CL; Fong TH; Lin KH; Chou DS; Sheu JR
    Br J Haematol; 2007 Nov; 139(3):475-85. PubMed ID: 17868048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.